Literature DB >> 8558093

Serum concentration of 7 alpha-hydroxycholesterol as an indicator of bile acid synthesis in humans.

C Hahn1, C Reichel, K von Bergmann.   

Abstract

The serum concentration of 7 alpha-hydroxycholesterol as an indicator of total bile acid synthesis was investigated under different experimental conditions in humans. 7 alpha-Hydroxycholesterol was measured by gas-liquid chromatography-mass spectrometry, using [2H7]7 alpha-hydroxycholesterol and/or 5 alpha-cholestane-3 beta, 6 beta-diol as internal standards, and bile acid synthesis was estimated by the fecal balance method. Intraindividual variation was small when the concentration of 7 alpha-hydroxycholesterol was determined twice in the same subject 2 days to 11 months apart (7.3 +/- 6.5%, n = 52). In patients with advanced cirrhosis of the liver (n = 22) 7 alpha-hydroxycholesterol was 3.4-fold lower (22 ng/ml +/- 8) compared to matched controls (75 ng/ml +/- 19). Administration of cholestyramine (4 g b.i.d.) for 14 days increased 7 alpha-hydroxycholesterol concentration in five healthy volunteers from 40 +/- 11 ng/ml to 181 +/- 95 ng/ml (P = 0.02) and fecal excretion of acidic sterols from 254 +/- 60 mg/d to 1336 +/- 344 mg/d (P < 0.01). Although a significant correlation was found between 7 alpha-hydroxycholesterol in serum and bile acid synthesis in patients with hypercholesterolemia (r = 0.847, P < 0.001, n = 17), it was impossible to accurately determine bile acid synthesis from the serum levels of 7 alpha-hydroxycholesterol. Thus, determination of 7 alpha-hydroxycholesterol concentrations in serum can be used to assess changes in bile acid synthesis rates over short and long term periods under various experimental conditions, but not to calculate bile acid synthesis correctly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8558093

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  15 in total

1.  Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals.

Authors:  Olga Renner; Simone Harsch; Silke Matysik; Dieter Lütjohann; Gerd Schmitz; Eduard F Stange
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

2.  Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1(-/-) mice fed low levels of cholic acid.

Authors:  Ryan D Jones; Joyce J Repa; David W Russell; John M Dietschy; Stephen D Turley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-24       Impact factor: 4.052

3.  Levels of 7alpha-hydroxycholesterol and/or 7alpha-hydroxy-4-cholest-3-one are the optimal biochemical markers for the evaluation of treatment of cerebrotendinous xanthomatosis.

Authors:  Dieter Lütjohann; Frans Stellaard; Ingemar Björkhem
Journal:  J Neurol       Date:  2019-11-28       Impact factor: 4.849

4.  Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Lauren N Bell; Jacob Wulff; Megan Comerford; Raj Vuppalanchi; Naga Chalasani
Journal:  Liver Int       Date:  2014-09-22       Impact factor: 5.828

5.  Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands.

Authors:  Yongjun Wang; Naresh Kumar; Laura A Solt; Timothy I Richardson; Leah M Helvering; Christine Crumbley; Ruben D Garcia-Ordonez; Keith R Stayrook; Xi Zhang; Scott Novick; Michael J Chalmers; Patrick R Griffin; Thomas P Burris
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

6.  The ABCG8 G574R variant, serum plant sterol levels, and cardiovascular disease risk in the Old Order Amish.

Authors:  Richard B Horenstein; Braxton D Mitchell; Wendy S Post; Dieter Lütjohann; Klaus von Bergmann; Kathleen A Ryan; Michael Terrin; Alan R Shuldiner; Nanette I Steinle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

7.  Simultaneous evaluation of HMG-CoA reductase and cholesterol 7alpha-hydroxylase activities by electrospray tandem MS.

Authors:  Marie-Yvonne Ndong-Akoume; Diane Mignault; Shahid Perwaiz; Gabriel L Plaa; Ibrahim M Yousef
Journal:  Lipids       Date:  2002-11       Impact factor: 1.880

8.  Oncogenic roles of the cholesterol metabolite 25-hydroxycholesterol in bladder cancer.

Authors:  Chen Wang; Haowei He; Wennian Fang
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

9.  Determination of key intermediates in cholesterol and bile acid biosynthesis by stable isotope dilution mass spectrometry.

Authors:  Tadashi Yoshida; Akira Honda; Hiroshi Miyazaki; Yasushi Matsuzaki
Journal:  Anal Chem Insights       Date:  2008-03-25

10.  Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.

Authors:  Marialena Mouzaki; Alice Y Wang; Robert Bandsma; Elena M Comelli; Bianca M Arendt; Ling Zhang; Scott Fung; Sandra E Fischer; Ian G McGilvray; Johane P Allard
Journal:  PLoS One       Date:  2016-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.